In past quarter of the century, much has been understood about the genetic variation and abnormal genes that activate cancer in humans. All the cancers somehow possess alterations in the DNA sequence of cancer cell's genome. In present, we are heading toward the era where it is possible to obtain complete genome of the cancer cells for their better diagnosis, categorization and to explore treatment options.
Keywords: Cancer; Genomics; Microarray; Multiomics; NGS; Sequencing.
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.